MS
VRTX icon

Maven Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Maven Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,588
Closed -$788K – 1311
2021
Q4 		$788K Buy
+3,588
New +$698K 0.1% 426
2021
Q2 		– Sell
-4,328
Closed -$905K – 1513
2021
Q1 		$931K Buy
4,328
+528
+14% +$116K 0.09% 449
2020
Q4 		$898K Buy
3,800
+763
+25% +$175K 0.09% 266
2020
Q3 		$830K Buy
3,037
+2,283
+303% +$630K 0.12% 279
2020
Q2 		$219K Sell
754
-646
-46% -$175K 0.06% 485
2020
Q1 		$333K Buy
+1,400
New +$321K 0.21% 216
2017
Q1 		– Sell
-219
Closed -$16K – 64
2016
Q4 		$16K Buy
+219
New +$17.8K 0.01% 43

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return